An innovative regenerative medicine and cellular therapy company targeting autoimmune diseases and inflammatory disorders. We generate revenue from our other technologies through a number of other activities, including through the sale of our stem cell products and cell lines. These products include native mesenchymal stem cells, several lines of Cancer-Associated Fibroblasts and native fibroblasts that are used by these institutions for stem cell research and the development of advanced immunotherapy of cancer. Additionally, we sell cosmeceuticals through InfiniVive MD, LLC (“InfiniVive MD”), our wholly owned subsidiary, to plastic surgeons, cosmetic surgeons, aestheticians and consumers in the United States and internationally, which helps to alleviate our capital expenses.
